• Publications
  • Influence
Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: a pilot study.
To investigate the safety and tolerability of the atypical antipsychotic quetiapine in anorexia nervosa patients, and to determine the effect of quetiapine treatment on anorexic psychopathology andExpand
  • 41
  • 2
Phospholipase A2 activity in first episode schizophrenia: Associations with symptom severity and outcome at week 12
Abstract Objectives. Intracellular phospholipases A2 (inPLA2) are activated during monoaminergic neurotranismision and act as key enzymes in cell membrane repair and remodelling, neuroplasticity,Expand
  • 21
  • 2
Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of
OBJECTIVE To assess dosing, efficacy, and tolerability of quetiapine fumarate in drug-naive first-episode psychosis. METHOD We present a prospective, randomized, controlled, single-center,Expand
  • 25
  • 2
Enhanced cortisol suppression following administration of low-dose dexamethasone in first-episode psychosis patients
Objective: Impaired regulation of the hypothalamic-pituitary-adrenal (HPA) axis and hyper-activity of this system have been described in patients with psychosis. Conversely, some psychiatricExpand
  • 23
  • 1
Incorporating Course-Based Undergraduate Research Experiences into Analytical Chemistry Laboratory Curricula
A continuous effort within an undergraduate university setting is to improve students’ learning outcomes and thus improve students’ attitudes about a particular field of study. This is undoubtedlyExpand
  • 24
  • 1
Bromide-Assisted Anisotropic Growth of Gold Nanoparticles as Substrates for Surface-Enhanced Raman Scattering
We report herein a one-step synthesis of gold nanoparticles (Au NPs) of various shapes such as triangles, hexagons, and semispheres, using 5-hydroxyindoleacetic acid (5-HIAA) as the reducing agent inExpand
  • 3
  • PDF